| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,433 |
3,280 |
$226K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,952 |
1,941 |
$111K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,544 |
1,535 |
$100K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,619 |
3,789 |
$99K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,576 |
1,559 |
$91K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,002 |
1,910 |
$85K |
| 92587 |
|
3,744 |
3,717 |
$73K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
911 |
849 |
$47K |
| 99051 |
|
976 |
958 |
$20K |
| 83655 |
|
1,192 |
1,174 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
502 |
493 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,839 |
1,832 |
$13K |
| 81002 |
|
3,720 |
3,689 |
$10K |
| 36416 |
|
3,098 |
3,066 |
$8K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
109 |
109 |
$6K |
| 99401 |
|
699 |
695 |
$6K |
| 88738 |
|
1,251 |
1,238 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
146 |
140 |
$4K |
| 80061 |
Lipid panel |
304 |
303 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
450 |
448 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
36 |
36 |
$2K |
| 85018 |
|
874 |
853 |
$2K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
12 |
12 |
$1K |
| 99177 |
|
151 |
151 |
$1K |
| 90686 |
|
1,348 |
1,312 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
51 |
51 |
$652.79 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$643.99 |
| 90651 |
|
524 |
518 |
$638.78 |
| 82947 |
|
104 |
104 |
$393.36 |
| 90734 |
|
520 |
516 |
$370.67 |
| 90698 |
|
712 |
697 |
$320.00 |
| 90633 |
|
173 |
170 |
$310.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
24 |
24 |
$292.09 |
| D1208 |
Topical application of fluoride, excluding varnish |
18 |
18 |
$263.25 |
| 90670 |
|
662 |
643 |
$255.00 |
| 90715 |
|
132 |
132 |
$249.33 |
| 81025 |
|
29 |
29 |
$194.38 |
| 90744 |
|
162 |
159 |
$85.00 |
| 90710 |
|
80 |
80 |
$75.00 |
| 96127 |
|
14 |
14 |
$57.78 |
| 90680 |
|
225 |
216 |
$50.00 |
| 90696 |
|
28 |
28 |
$25.00 |
| 90685 |
|
45 |
42 |
$15.00 |
| 90473 |
|
13 |
13 |
$0.00 |